Zuzana Moťovská

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

Marco Valgimigli, Héctor Bueno, Robert A. Byrne et al. · European Heart Journal · 2017 · 3K citations · Full text

Medicine, Cardiology, Pharmacotherapy +14

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al. · The Lancet · 2017 · 880 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch et al. · The Lancet · 2017 · 756 citations · Full text

Medicine, Cardiology, Pharmacology +13

Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes

Gilles Montalescot, Leonardo Bolognese, Dariusz Dudek et al. · New England Journal of Medicine · 2013 · 648 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

Medicine, Cardiology, Internal Medicine +15